Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Clinical Trial

Comparative Study

Clinical Trial, Phase II

Clinical Trial, Phase I

Multicenter Study

Clinical Trial, Phase III

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial Protocol

Meta-Analysis

Systematic Review

Case Reports

Research Support, U.S. Gov't, P.H.S.

Historical Article

Observational Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2023

2021

2020

2019

2018

2017

2016

2015

2014

2012

2006

2004

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Poliomyelitis""[mesh_terms]

34 Results

Searching titles within these results

Medical Comorbidities and Complications Associated with Poliomyelitis and Its Sequelae.

Lauren T Shapiro, Andrew L Sherman

Physical medicine and rehabilitation clinics of North America 2021;32(3):591-600

Full Text

Abstract

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus.

Graciela Matrajt, Brienna Naughton, Ananda S Bandyopadhyay, John Scott Meschke

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019;67(suppl_1):S90-S97

Free Full Text

Abstract

Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability.

Jalaa Abdelwahab, Vance Dietz, Rudolf Eggers, Christopher Maher, Marianne Olaniran, Hardeep Sandhu, Jos Vandelaer

The Journal of infectious diseases 2014;210 Suppl 1(Suppl 1):S498-503

Free Full Text

Abstract

A randomized controlled trial of coenzyme Q10 for fatigue in the late-onset sequelae of poliomyelitis.

Margaret M Peel, Marie Cooke, Helen J Lewis-Peel, Rodney A Lea, Wendy Moyle

Complementary therapies in medicine 2016;23(6):789-93

Full Text

Abstract

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.

Lulu C Bravo, Josefina C Carlos, Salvacion R Gatchalian, May Emmeline B Montellano, Charissa Fay Corazon B Tabora, Birgit Thierry-Carstensen, Pernille Nyholm Tingskov, Charlotte Sørensen, Henrik Wachmann, Ananda S Bandyopadhyay, Pernille Ingemann Nielsen, Mie Vestergaard Kusk

Vaccine 2021;38(3):530-538

Free Full Text

Abstract

A Low-Cost, Integrated Immunization, Health, and Nutrition Intervention in Conflict Settings in Pakistan-The Impact on Zero-Dose Children and Polio Coverage.

Muhammad Islam, Rehman Tahir, Saeed Anwar, Imran Ahmed, Zulfiqar A Bhutta, Amira M Khan, Muhammad Jawwad, Ahmed Ali Nauman

Pathogens (Basel, Switzerland) 2025;13(3):

Free Full Text

Abstract

Campaigns with oral polio vaccine may lower mortality and create unexpected results.

C S Benn, L H Jacobsen, A B Fisker, A Rodrigues, E Sartono, N Lund, H C Whittle, P Aaby

Vaccine 2017;35(8):1113-1116

Free Full Text

Abstract

Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.

James A Church, Sandra Rukobo, Margaret Govha, Marya P Carmolli, Sean A Diehl, Bernard Chasekwa, Robert Ntozini, Kuda Mutasa, Jean H Humphrey, Beth D Kirkpatrick, Andrew J Prendergast

Transactions of the Royal Society of Tropical Medicine and Hygiene 2020;113(3):110-115

Free Full Text

Abstract

Accuracy of Resting Energy Expenditure Estimation Equations in Polio Survivors.

François Genêt, Marjorie Salga, Gratiane De Brier, Arnaud-Xavier Jouvion, Guillaume Genêt, Frédéric Lofaso, Hélène Prigent, Maxime Obrecht, Sophie Dziri, Laurent Théfenne

Archives of physical medicine and rehabilitation 2023;104(3):418-424

Full Text

Abstract

Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.

Marta Sanz-Ramos, Daniela Manno, Mirriam Kapambwe, Ida Ndumba, Kunda G Musonda, Matthew Bates, Julia Chibumbya, Joshua Siame, Mwaka Monze, Suzanne Filteau, Ursula A Gompels

Vaccine 2014;31(16):2042-9

Full Text

Abstract

Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial.

Subhash Chandir, Kabir U Ahamed, Abdullah H Baqui, Roland W Sutter, Hiromasa Okayasu, Mark A Pallansch, Mark S Oberste, Lawrence H Moulton, Neal A Halsey

The Journal of infectious diseases 2014;210 Suppl 1():S390-7

Full Text

Abstract

Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial.

Bastiaan A Blok, L Charlotte J de Bree, Dimitri A Diavatopoulos, Jeroen D Langereis, Leo A B Joosten, Peter Aaby, Reinout van Crevel, Christine S Benn, Mihai G Netea

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021;70(3):455-463

Full Text

Abstract

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).

Daniel Cowley, Rini Mulia Sari, Amanda Handley, Emma Watts, Novilia S Bachtiar, Jarir At Thobari, Cahya Dewi Satria, Nada Bogdanovic-Sakran, Hera Nirwati, Francesca Orsini, Katherine J Lee, Carl D Kirkwood, Yati Soenarto, Julie E Bines

Vaccine 2020;37(49):7233-7239

Free Full Text

Abstract

Stopping live vaccines after disease eradication may increase mortality.

Peter Aaby, Christine S Benn

Vaccine 2021;38(1):10-14

Full Text

Abstract

Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial.

M A Habib, S Soofi, A Sheraz, Z S Bhatti, H Okayasu, S Z Zaidi, N A Molodecky, M A Pallansch, R W Sutter, Zulfiqar A Bhutta

Vaccine 2015;33(6):819-25

Full Text

Abstract

Results: 1 – 15 / 34

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Poliomyelitis""[mesh_terms]

Medical Comorbidities and Complications Associated with Poliomyelitis and Its Sequelae.

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus.

Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability.

A randomized controlled trial of coenzyme Q10 for fatigue in the late-onset sequelae of poliomyelitis.

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.

A Low-Cost, Integrated Immunization, Health, and Nutrition Intervention in Conflict Settings in Pakistan-The Impact on Zero-Dose Children and Polio Coverage.

Campaigns with oral polio vaccine may lower mortality and create unexpected results.

Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.

Accuracy of Resting Energy Expenditure Estimation Equations in Polio Survivors.

Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.

Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial.

Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial.

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).

Stopping live vaccines after disease eradication may increase mortality.

Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial.

Results for
""Poliomyelitis""[mesh_terms]

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.